Potassium Phosphates (Hospira, Inc.)
Welcome to the PulseAid listing for the Potassium Phosphates drug offered from Hospira, Inc.. This Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | POTASSIUM PHOSPHATE, MONOBASIC and POTASSIUM PHOSPHATE, DIBASIC |
SUBSTANCE NAME: | POTASSIUM PHOSPHATE, MONOBASIC; DIBASIC POTASSIUM PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 1984-09-17 |
END MARKETING DATE: | 0000-00-00 |
Potassium Phosphates HUMAN PRESCRIPTION DRUG Details:
Item Description | Potassium Phosphates from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 224; 236(mg/mL; mg/mL) |
START MARKETING DATE: | 1984-09-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-7295_a5a805c5-d00a-43c3-bc2b-c87caf9f3d89 |
PRODUCT NDC: | 0409-7295 |
APPLICATION NUMBER: | |
Other POTASSIUM PHOSPHATE, MONOBASIC; DIBASIC POTASSIUM PHOSPHATE Pharmaceutical Manufacturers / Labelers: